Results for tag: "Night Vision Disturbance Drug"

The Night Vision Disturbance Drug market is a subset of the Optical Disorders Drugs market. It is composed of drugs used to treat night vision disturbances, such as night blindness, glare sensitivity, and poor night vision. These drugs are typically used to improve the vision of patients with retinal diseases, such as retinitis pigmentosa, or to treat other eye conditions, such as cataracts. The drugs are usually administered orally or topically, and may include vitamins, minerals, and other nutrients. The Night Vision Disturbance Drug market is highly competitive, with many companies offering products to treat night vision disturbances. Some of the major players in the market include Allergan, Bausch + Lomb, Novartis, Pfizer, and Santen Pharmaceuticals. Other companies in the market include Alcon, Merck, and Sun Pharmaceuticals. Show Less Read more